Threshold Total System (110V)

Products	Threshold Total System (110V)
Company	Molecular Devices Corporation
Item	Threshold Total System (110V)
Features	Inquire
Description	A system used to detect and quantitate contaminants, such as residual host cell DNA, host cell protein, bovine contaminants (e.g., BSA, IgG, insulin, transferrin), Proteins A and G, and any unique protein that can be bound by antibodies as well as sequence-specific DNA and plasmid copy number. The system reduces the time required to develop, validate, and perform ultra-sensitive assays with maximum speed, sensitivity, reproducibility, and reliability, and it provides tools for FDA 21 CFR compliance. System uses non-radioactive detection, and has a wide dynamic range, typically 2 logs or better. Contains four 8-channel filtration units, with the possibility of adding two auxiliary manifolds, for a total simultaneous filtration of 96 samples during a 90-second kinetic measurement. Choice of Total DNA Starter Kit or Imunoligand (ILA) Starter Kit included. Total DNA Assay Kit (R9009), DNA Assay bulk kit (R9004) and ILA Detection Kit (R9003) and ILA Labeling Kit (R9002) are sold separately.
Info	Molecular Devices Corporation Customer Service: (800) 635-5577 Web site: http://www.moleculardevices.com/

TAG: Threshold Total System

Universal Wrist/Forearm Splint

Contoured Wrist/Forearm

ManuTrain

...apeutic benefits of controlled compression to mini...ze pain. The versatile design of the cuff allows i...For added support, support bars are incorporated i...motion is desired.,All Cryo/Cuffs can be ordered ...

Medicine Products:

Universal Wrist/Forearm Splint Contoured Wrist/Forearm ManuTrain Hand and Wrist Cryo/Cuff™

(Date:12/3/2009)...n the life-long focus of his research and now, Pet...mprehensive Cancer Center at Georgetown University...ial-edition of Cancer Epidemiology, Biomarkers & ...actices in tobacco science from researchers the wo...nal of the American Association for Cancer Researc...

(Date:12/2/2009)...SNewswire/ -- The American Association of Poison C...ional Poison Center in Minneapolis, Minnesota as a...tone for the center. The designation by the AAPCC...58 accredited poison centers in the United States....hment. It means we have met the national standards...

(Date:12/2/2009).../ -- Reportlinker.com announces that a new market ..., Renal Disease Treatments: Products and Therapi...nal-Disease-Treatments-Products-and-Therapies.html...and services, providing data for 2008 and estimate...pound annual growth rates (CAGRs) from 2009 to 201...

(Date:12/2/2009).../ -- Reportlinker.com announces that a new market ..., Point of Care Diagnostics ,, http://www.r....html ,, Provides a complete review and analys... ,, Includes market forecasts through 2014 for ...deral regulation of POC testing ,, Analyzes ma...

(Date:12/2/2009).../ -- Reportlinker.com announces that a new market ..., Antibiotic Resistance and Antibiotic Technolog...r.com/p0166825/Antibiotic-Resistance-and-Antibioti...an in-depth review of the global market for antibi..., Offer an analysis of antibiotics resistance from...

[0] Lombardi's Shields leads special journal focused on tobacco research [1] Hennepin Regional Poison Center Designated as an Accredited Poison Control Center [1] Reportlinker Adds Renal Disease Treatments: Products and Therapies [0] Reportlinker Adds Point of Care Diagnostics [0] Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets

...t receiving the support they need to stop smoking,...ths from cardiovascular and respiratory illnesses....ffith Universitys School of Medicine, health servi...ss disorder. , He said smoking rates in people w...

...tCall/ - AlphaRx (OTC BB:ALRX -,News), an emerging...rug,delivery technology to develop novel formulati...ical development of Indaflex(TM), its topical NSAI... Cypress acquired Proprius Pharmaceuticals, Inc.,(...

... innovative,weight-loss tool is proud to announce ...rday, May 10th, in less than its first year of ope... alternative among consumers,looking for a healthy...nlike other weight-loss programs, portionpals(R) d...

...c.,(Nasdaq: MEDX ) announced today its financial ...cluding a gain of $151.8 million, or $1.19 per sha...enmab A/S stock in February 2008, Medarex,s,net in...or the same period in 2007. In addition to the gai...

...poration,(Nasdaq: MDTH ), a health care provider ...minantly the diagnosis and treatment of cardiovasc...ior Vice-President and,Treasurer and currently Int...ue to oversee and direct Treasury and,other Financ...

...an,Veterinary Medical Association (AVMA) has revis...e to provide veterinarians with additional guidanc...es. The revised policy,approved on April 12, 2008,...ation by practitioners when they work,with produce...

Other Medicine News:Health News:Quit smoking message not getting air time in mental health care 2 Health News:AlphaRx's Indaflex(TM) Continues its Clinical Development 2 Health News:Diet Industry Newcomer Hits the 1 Million Unit Mark 2 Health News:Medarex Announces 2008 First Quarter Financial Results 2 Health News:Medarex Announces 2008 First Quarter Financial Results 3 Health News:Medarex Announces 2008 First Quarter Financial Results 4 Health News:Medarex Announces 2008 First Quarter Financial Results 5 Health News:Medarex Announces 2008 First Quarter Financial Results 6 Health News:Medarex Announces 2008 First Quarter Financial Results 7 Health News:Medarex Announces 2008 First Quarter Financial Results 8 Health News:MedCath Names Parker to New Finance Post 2 Health News:Revised AVMA Policy on Castrating and Dehorning Cattle Provides Additional Guidance for Managing Pain 2

Quit smoking message not getting air time in mental health care AlphaRx's Indaflex(TM) Continues its Clinical Development Diet Industry Newcomer Hits the 1 Million Unit Mark Medarex Announces 2008 First Quarter Financial Results MedCath Names Parker to New Finance Post Revised AVMA Policy on Castrating and Dehorning Cattle Provides Additional Guidance for Managing Pain

(Date:12/3/2009)...Newswire/ -- Upsher-Smith Laboratories, Inc. today...r central nervous system (CNS) diseases with USL25...eloped program for the management of epilepsy. USL...tary formulation technology and will enter a phase...ve treatment of epilepsy patients with partial ons...

(Date:12/3/2009)...-FirstCall/ -- VirtualScopics, Inc. (Nasdaq: VSC...r clinical trials, announced today that its patent...nd Visualization" recently received issuance in Ja...ology and Product Development, Dr. Jonathan Riek, ...the uniqueness of VirtualScopics, science by joini...

(Date:12/3/2009)...lands, December 3 arGEN-X BV, a,bi...nd development of human,antibodies using its propr...ed the successful second closing of its Series A e...ional EUR 3.0 million (~USD 4.5 million),from two ...ivate Equity and,VIB (the prestigious Flemish rese...

Breaking Medicine Technology:Upsher-Smith Announces Milestone in Development of CNS Strategy 2 VirtualScopics Receives Issuance in Japan of Prominent Patent 2 VirtualScopics Receives Issuance in Japan of Prominent Patent 3 arGEN-X Concludes EUR 12.5 Million Series A Financing Round 2 arGEN-X Concludes EUR 12.5 Million Series A Financing Round 3 arGEN-X Concludes EUR 12.5 Million Series A Financing Round 4 Stretching Test May Reveal Arterial Stiffness 59206 1 Stretching Test May Reveal Arterial Stiffness 59206 2 Smart For Life 28TM 29 Makes Debut on BJs com 59203 1 Smart For Life 28TM 29 Makes Debut on BJs com 59203 2 Smart For Life 28TM 29 Makes Debut on BJs com 59203 3 Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early Stage 59200 1 Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early Stage 59200 2 Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early Stage 59200 3 Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early Stage 59200 4 Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early Stage 59200 5

[0] Upsher-Smith Announces Milestone in Development of CNS Strategy [0] VirtualScopics Receives Issuance in Japan of Prominent Patent [0] arGEN-X Concludes EUR 12.5 Million Series A Financing Round